Literature DB >> 7650759

Correlates between nuclear magnetic resonance spectroscopy, diffusion weighted imaging, and CA1 morphometry following chronic brain ischemia.

J C de la Torre1, K Butler, P Kozlowski, T Fortin, J K Saunders.   

Abstract

Chronic brain ischemia (CBI) was induced in aging (13 month) rats by ligating the left subclavian artery and placing temporary occluders in each common carotid artery [three-vessel occlusion (3-VO)]. Carotid artery occluders were removed after 1, 2, or 3 weeks following brain ischemia or maintained for 9 weeks. Two rats were kept with their occluders in place for 25 weeks. On weeks 3 and 9 after CBI, 31P-/1H-nuclear magnetic resonance (NMR) spectroscopy and high resolution diffusion weighted imaging were performed in vivo, non-invasively for detection of hippocampal high energy phosphates, lactate, intracellular pH, N-acetyl-aspartate, choline, glutamate, creatine, and structural alterations of the brain following CBI. Brains were histologically processed for morphometry of glial fibrillary acidic protein (GFAP) and CA1 damaged neurons 9 weeks after CBI. 31P-/1H-NMR spectroscopy showed that high energy substrates remained normal in ischemic animals when compared to non-ischemic controls except for an elevation of phosphomonesters in the hippocampal region. Rats deoccluded 1 and 2 weeks after initiation of CBI had no NMR spectroscopic or imaging changes. Rats kept ischemic for 9 weeks showed high signal intensities in the parietal cortex detected by diffusion weighted imaging as well as CA1 damage and increased GFAP density but no cortical atrophy or neuronal damage could be detected histologically. Rats kept ischemic for 25 weeks showed extensive cortical atrophy which corresponded to the high signal intensity observed with diffusion weighted imaging in the group kept ischemic for 9 weeks.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7650759     DOI: 10.1002/jnr.490410211

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  9 in total

1.  S-nitrosoglutathione reduces tau hyper-phosphorylation and provides neuroprotection in rat model of chronic cerebral hypoperfusion.

Authors:  Je-Seong Won; Balasubramaniam Annamalai; Seungho Choi; Inderjit Singh; Avtar K Singh
Journal:  Brain Res       Date:  2015-08-10       Impact factor: 3.252

2.  The GRK2 Overexpression Is a Primary Hallmark of Mitochondrial Lesions during Early Alzheimer Disease.

Authors:  Mark E Obrenovich; Hector H Palacios; Eldar Gasimov; Jerzy Leszek; Gjumrakch Aliev
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-03-03

3.  Creatine kinase reaction rates in rat brain during chronic ischemia.

Authors:  V Mlynárik; S Kasparová; T Liptaj; D Dobrota; J Horecký; V Belan
Journal:  MAGMA       Date:  1998-12       Impact factor: 2.310

4.  Overexpression of GRK2 in Alzheimer disease and in a chronic hypoperfusion rat model is an early marker of brain mitochondrial lesions.

Authors:  Mark E Obrenovich; Mark A Smith; Sandra L Siedlak; Shu G Chen; Jack C de la Torre; George Perry; Gjumrakch Aliev
Journal:  Neurotox Res       Date:  2006-08       Impact factor: 3.911

5.  Protective role of S-nitrosoglutathione (GSNO) against cognitive impairment in rat model of chronic cerebral hypoperfusion.

Authors:  Je-Seong Won; Jinsu Kim; Balasubramaniam Annamalai; Anandakumar Shunmugavel; Inderjit Singh; Avtar K Singh
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 6.  Molecular Mechanisms of Vascular Dementia: What Can Be Learned from Animal Models of Chronic Cerebral Hypoperfusion?

Authors:  Si-Qi Du; Xue-Rui Wang; Ling-Yong Xiao; Jian-Feng Tu; Wen Zhu; Tian He; Cun-Zhi Liu
Journal:  Mol Neurobiol       Date:  2016-05-20       Impact factor: 5.590

Review 7.  Diffusion tensor imaging in Alzheimer's disease and mild cognitive impairment.

Authors:  G T Stebbins; C M Murphy
Journal:  Behav Neurol       Date:  2009       Impact factor: 3.342

Review 8.  Insights into cerebrovascular complications and Alzheimer disease through the selective loss of GRK2 regulation.

Authors:  Mark E Obrenovich; Ludis A Morales; Celia J Cobb; Justin C Shenk; Gina M Méndez; Kathryn Fischbach; Mark A Smith; Eldar K Qasimov; George Perry; Gjumrakch Aliev
Journal:  J Cell Mol Med       Date:  2008-10-06       Impact factor: 5.310

Review 9.  Vascular dysfunction associated with type 2 diabetes and Alzheimer's disease: a potential etiological linkage.

Authors:  Fuzhou Wang; Xirong Guo; Xiaofeng Shen; Richard M Kream; Kirk J Mantione; George B Stefano
Journal:  Med Sci Monit Basic Res       Date:  2014-08-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.